Back to search

Zydus Pharmaceuticals Uk Ltd

14646636

active
Private Limited Company
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Loss before tax (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

GROUND FLOOR, BRISTOL, BS1 6FL
Incorporated 08/02/2023

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

46460
Wholesale of pharmaceutical goods

Officers

Vistra Cosec Limited

secretary · Since 08/02/2023

AMERICAN

Also on 1119 other boards

Naik Amrut Diwakar

director · Since 08/02/2023

DIRECTOR

INDIAN · INDIA · Age 50

Mr Akhil Arun Monappa

director · Since 08/02/2023

DIRECTOR

INDIAN · UNITED KINGDOM · Age 47

Also on 1 other board

Mr Kamlesh Kanubhai Patel

director · Since 08/02/2023

MANAGING DIRECTOR

BRITISH · ENGLAND · Age 67

Also on 7 other boards

Persons with Significant Control

Mr Pankaj Ramanbhai Patel

ownership-of-shares-50-to-75-percent-as-trust
voting-rights-50-to-75-percent-as-trust
right-to-appoint-and-remove-directors-as-trust

Indian · India · Age 73

16, Azad Society, Ambawadi, Ahmedabad-380015

Notified 08/02/2023

Mrs Pritiben Pankajbh Patel

ownership-of-shares-50-to-75-percent-as-trust
voting-rights-50-to-75-percent-as-trust
right-to-appoint-and-remove-directors-as-trust

Indian · India · Age 70

16, Azad Society, Ambawadi, Ahmedabad-380015

Notified 08/02/2023

Dr Sharvil Pankajbhai Patel

ownership-of-shares-50-to-75-percent-as-trust
voting-rights-50-to-75-percent-as-trust
right-to-appoint-and-remove-directors-as-trust

Indian · India · Age 47

16, Azad Society, Ambawadi, Ahmedabad-380015

Notified 08/02/2023

CompanyRankvs 285+ SIC 46460 peers
68

Financial strength100th percentile among SIC peers · 25/25
Employees100th percentile among SIC peers · 15/15
LiquidityCurrent ratio 2.64× · 20/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Rayburn Trading Company Limited
90
2Servier Laboratories Limited
90
3P & A J Cattee (Wholesale) Ltd.
90
4Hameln Pharma Ltd
90
5Day Lewis Medical Limited
90
6Kinetic Enterprises Limited
90
7Morningside Pharmaceuticals Limited
90
8A1 Pharmaceuticals Public Limited Company
90
9Greiner Bio-One Limited
90
10Trafalgar Scientific Limited
90
285Zydus Pharmaceuticals Uk Ltd
78
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the entity's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going conce

Key FinancialsYear ending 31/03/2024

Turnover

£5.6M

Annual revenue

Net Worth

£70.0M

Balance sheet strength

Cash

£1.7M

Cash in the bank

Profit Before Tax

-£5.2M

Bottom line earnings

Net Current Assets

£8.6M

Working capital

Current Assets

£13.9M

Current Liabilities

£5.3M

Fixed Assets

£160.5M

Debtors

£10.6M

Cost of Sales

£993k

Gross Profit

£4.6M

Admin Expenses

£7.5M

Operating Profit

-£2.9M

Profit After Tax

£63k

97avg. employees

Tax at Year End

Corp tax£49k

People Costs

Wages & salaries£1.6M
NI contributions£149k

Balance Sheet

Intangible assets£157.9M
Assets less current liabilities£169.1M
Signed by Mr Kamlesh Patel 6 February 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent Ratio
20242.64

Derived from filed accounts. Not audited figures.